Zusammenfassung
Wir berichten über eine 70-jährige Patientin mit einem vernarbenden Pemphigoid der Haut und Schleimhäute, die mit einer Kombinationstherapie aus Mycophenolatmofetil und Prednisolon behandelt wurde. Hierunter kam es zu einer vollständigen Abheilung der Läsionen, und unerwünschte Nebenwirkungen wurden nicht beobachtet.
Abstract
A 70-year-old woman with cicatricial pemphigoid of the skin and oral mucosa was treated with a combination of mycophenolate mofetil and prednisolone. This treatment led to complete remission of all lesions, and no side effects were observed.
Literatur
Ahmed AR, Hombal SM (1986) Cicatricial pemphigoid. Int J Dermatol 25:90–96
Bhol KC, Goss L, Kumari S et al. (2001) Autoantibodies to human alpha6 integrin in patients with oral pemphigoid. J Dent Res 80:1711–1715
Boehm M, Beissert S, Schwarz T et al. (1997) Bullous pemphigoid treated with mycophenolate mofetil. Lancet 349:541
Chan LS, Majmudar AA, Tran HH et al. (1997) Laminin-6 and laminin-5 are recognized by autoantibodies in a subset of cicatricial pemphigoid. J Invest Dermatol 108:848–853
Egan CA, Lazarova Z, Darling TN et al. (2003) Anti-epiligrin cicatricial pemphigoid.Clinical findings, immunopathogenesis and significant associations. Medicine 82:177–186
Enk AH, Knop J (1997) Treatment of pemphigus vulgaris with mycophenolate mofetil. Lancet 350:494
European Mycophenolate Mofetil Cooperative Study Group (1995) Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet 345:1321–1325
Fleming TE, Korman NJ (2000) Cicatricial pemphigoid. J Am Acad Dermatol 43:571–591
Foster CS, Ahmed AR (1999) Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid: a preliminary study. Ophthalmology 106:2136–2143
Hashimoto Y, Suga Y, Yoshiike T et al. (2000) A case of antiepiligrin cicatricial pemphigoid successfully treated by plasmapheresis. Dermatology 201:58–60
Labib RS, Anhalt GJ, Patel HP et al. (1986) Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. J Immunol 136:1231–1235
Lazor JB, Varvares MA, Montgomery WW et al. (1996) Management of airway obstruction in cicatricial pemphigoid. Laryngoscope 106:1014–1017
Leverkus M, Bhol K, Hirako J et al. (2001) Cicatricial pemphigoid with circulating autoantibodies to beta4 integrin, bullous pemphigoid 180 and bullous pemphigoid 230. Br J Dermatol 145: 998–1004
Lipsky J (1996) Mycophenolate mofetil. Lancet 348:1357–1359
Marren P, Wojnarowska F, Venning V et al. (1993) Vulvar involvement in autoimmune bullous diseases. J Reprod Med 38:101–107
Megahed M (in press) Histopathology of blistering diseases with clinical, electron microscopic, immunological, and molecular biological correlations. Springer, Berlin Heidelberg New York Tokyo
Megahed M, Schmiedeberg S, Becker J et al. (2001) Treatment of cicatricial pemphigoid with mycophenolate mofetil as a steroid-sparing agent. J Am Acad Dermatol 45:256–259
Neumann R, Tauber J, Foster CS (1991) Remission and recurrence after withdrawal of therapy for ocular cicatricial pemphigoid. Ophthalmology 98:858–862
Nousari HC, Sragovich A, Kimjai-Asadi A et al. (1999) Mycophenolate mofetil in autoimmune and inflammatory skin disorders. J Am Acad Dermatol 40:265–268
Olivry T, Dunston SM, Schachter M et al. (2001) A spontaneous canine model of mucous membrane (cicatricial) pemphigoid, an autoimmune blistering disease affecting mucosae and mucocutaneous junctions. J Autoimmun 16:411–421
Reis A, Reinhard T, Sundmacher R et al. (1998) Mycophenolatmofetil (CellCept) bei okulären immunologischen Störungen. Klin Monatsbl Augenheilkd 213:257–261
Tyagi S, Bhol K, Natarajan K et al. (1996) Ocular cicatricial pemphigoid antigen: partial sequence and biochemical characterization. Proc Natl Acad Sci USA 93:14714–14719
Yancey KB, Egan CA (2000) Pemphigoid: clinical, histologic, immunopathologic, and therapeutic considerations. JAMA 284:350–356
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Elser, I., Selimovic, D., Ruzicka, T. et al. Mycophenolatmofetil als effektive Therapieoption bei vernarbendem Pemphigoid. Hautarzt 54, 981–984 (2003). https://doi.org/10.1007/s00105-003-0595-1
Issue Date:
DOI: https://doi.org/10.1007/s00105-003-0595-1